The developer and supplier of biologically active plant-derived ingredients says that Soliprin has been scientifically developed as an all-natural skin care that adds to the company's burgeoning cosmeceutical product portfolio.
Currently that portfolio includes AloeWhite skin lightener and Immuno 10 antiaging treatment, together with a number of pharmaceutical and nutraceutical brands.
The company says that the development of Soliprin involved the screening of 1,230 plant extracts in an effort to identify natural botanical compounds that can help protect against environmental toxins and UV rays.
The product itself made its industry debut at the recently held 9th Annual SupplySide West International trade show in Las Vegas.
At the event Unigen chairman Marcus Laux gave a presentation that highlighted the product's ability to support healthy aging for the skin and to address minor skin irritation due to its antioxidant activities.
Dr. Qi Jia, Unigen's chief scientific officer said that the product had been launched to fight against these environmental pollutants and hazards as well as the emotional stresses skin is exposed to.
The skin care line is a blend of two novel plant extracts that the company says have been tested using gene expression, protein inhibition assays, cell-based studies and human clinical trials to provide potent antioxidant activities.
The company also claims that it has achieved an Oxygen Radical Absorbance Capacity (ORAC) value higher than 19,000 for Soliprin, which reflects a potency approximately four-fold that of vitamin C.
It also claims that the product has been shown to modulate prostaglandin and leukotriene pathways and down-regulate cytokine gene expression. This is said to result in reduction of skin inflammation and has shown an increase of Minimum Erythema Dosage (MED) on humans.
Unigen says that during development typical doses of between 0.5 to 1.5 per cent concentration showed no irritation, sensitization or phototoxicity in human clinical safety trials.
In April of this year Unigen announced that it was patenting aloesin and aloeresin A - antioxidant aloe chromones that are contained in its Pervarin and Aloewhite commercial raw materials.
The patent states that the ingredient is suitable for oral and topical formulations - making it ideal for use in skincare applications, as well as in supplements and food fortification.